INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 19S · 3 late74 trades$23.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04CFCheng Chi Fung0B / 42S42 trades$15.33M
  5. 05RARothblatt Martine A0B / 33S33 trades$5.50M
  6. 06RJRubinstein Julie0B / 32S32 trades$5.55M
  7. 07LBLeach Bryan0B / 30S30 trades$7.97M
  8. 08AOAtay Oguzhan0B / 30S30 trades$7.55M
  9. 09JDJenkins William D Jr0B / 30S30 trades$13.38M
  10. 10BSBiswas Sanjit0B / 28S28 trades$22.33M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  3. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  4. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  5. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  6. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  7. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K
  8. SELLBCYCBICYCLE THERAPEUTICS PLCOct 2 – Oct 56 insiders$63K

Form 4 transactions

7,671 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
36
AN
Agrawal NitinChief Financial Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.13M
13.4K sh
Mar 17, 2026Mar 19, 2026
Page 118 of 192
← PrevNext →
traded Mar 17, 2026
+2d
SEC Form 4

Evidence

35
NS
Neervannan SeshadriChief Operating Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$248K
3,610 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

35
EW
Eifler Robert W.Director, President & CEO
NENoble Corp plc
Open-market sale
SELL$1.28M
27.2K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

34
GJ
Gayford Michael JamesEVP of Operations
CMTCORE MOLDING TECHNOLOGIES INC
Open-market purchase
BUY$10K
500 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

33
SR
Stangl RolfDirector
REYNReynolds Consumer Products Inc.
Open-market purchase
BUY$49K
2,325 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

33
SR
Stangl RolfDirector
REYNReynolds Consumer Products Inc.
Open-market purchase
BUY$50K
2,380 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

33
RH
Robbins Edward Hutchinson Jr.EVP, General Counsel
TLSTELOS CORP
Open-market sale
SELL$149K
37.1K sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

33
SA
Sfadia AdiCEO
GILTGILAT SATELLITE NETWORKS LTD
Open-market sale
SELL$67K
3,978 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
ZT
Zalatoris TimmiChief Human Resources Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$40K
480 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
HL
Hurley Joseph LChief Supply Chain Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$38K
456 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
CK
Coffin KimSVP, Chief Forager
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$39K
467 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
VC
Valentine CurtisChief Financial Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$15K
183 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$26K
379 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale
SELL$27K
272 sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

32
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$5,468
172 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
LT
Leggett ThomasChief Financial Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$1,215
37 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale
SELL$29K
299 sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

32
ZT
Zalatoris TimmiChief Human Resources Officer
SFMSprouts Farmers Market, Inc.
Open-market sale
SELL$49K
585 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

32
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$4,419
139 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
HJ
Hoitt JasonChief Patient Officer
STOKStoke Therapeutics, Inc.
Open-market sale
SELL$986
30 sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
RH
Robbins Edward Hutchinson Jr.EVP, General Counsel
TLSTELOS CORP
Open-market sale
SELL$259K
64.5K sh
Mar 18, 2026Mar 19, 2026
traded Mar 18, 2026
+1dSEC Form 4

Evidence

32
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale
SELL$45K
460 sh
Mar 16, 2026Mar 19, 2026
traded Mar 16, 2026
+3dSEC Form 4

Evidence

32
JF
Jones Stephen FrancisDirector
WLFCWILLIS LEASE FINANCE CORP
Open-market sale
SELL$98K
587 sh
Mar 17, 2026Mar 19, 2026
traded Mar 17, 2026
+2dSEC Form 4

Evidence

32
LY
Lin Elizabeth YeuChief Medical Officer
TARSTarsus Pharmaceuticals, Inc.
Open-market sale
SELL$26K
390 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

30
LD
Lam DennisDirector
HFFGHF Foods Group Inc.
Open-market purchase
BUY$176
100 sh
Mar 19, 2026Mar 19, 2026
traded Mar 19, 2026
+0dSEC Form 4

Evidence

57
FJ
Fry David JamesGroup Head Projects & Studies
NEMNEWMONT Corp /DE/
Open-market sale
SELL$2.05M
18.4K sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

45
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.35M
4,134 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

45
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.56M
4,795 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

45
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.33M
4,069 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

45
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.98M
6,040 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

45
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.16M
3,574 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

44
LS
Lederman SethDirector, Chief Executive Officer
TNXPTonix Pharmaceuticals Holding Corp.
Open-market purchase
BUY$223K
15.0K sh
Mar 18, 2026Mar 18, 2026
traded Mar 18, 2026
+0dSEC Form 4

Evidence

42
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.82M
5,632 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence

42
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$266K
808 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

42
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$2.05M
6,405 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence

42
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$568K
1,758 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

42
CJ
Carroll Hugh JDirector
TXRHTexas Roadhouse, Inc.
Open-market sale
SELL$169K
988 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

39
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$116K
360 sh
Mar 16, 2026Mar 18, 2026
traded Mar 16, 2026
+2dSEC Form 4

Evidence

38
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.22M
3,839 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence

38
VR
Velaga S. RamPresident, ISG
AVGOBroadcom Inc.
Open-market sale
SELL$1.75M
5,423 sh
Mar 17, 2026Mar 18, 2026
traded Mar 17, 2026
+1dSEC Form 4

Evidence